Expression of the anti-Mullerian hormone, kisspeptin 1, and kisspeptin 1 receptor in polycystic ovary syndrome and controlled ovarian stimulation rat models

dc.contributor.authorRisvanli, Ali
dc.contributor.authorOcal, Halis
dc.contributor.authorTimurkaan, Necati
dc.contributor.authorIpek, Pinar
dc.contributor.authorSeker, Ibrahim
dc.contributor.authorKarabulut, Burak
dc.date.accessioned2026-08-12T16:42:14Z
dc.date.issued2020
dc.departmentFırat Üniversitesi
dc.description.abstractPolycystic ovary syndrome represents a significant cause of female infertility. The aim of this study was to investigate the expression of anti-Mullerian hormone (AMH), kisspeptin 1 (KISS-1), and kisspeptin 1 receptor (KISS1r) in rat models of polycystic ovary syndrome (PCOS) and controlled ovarian stimulation (COS). For this purpose. 28 rats were assigned into four groups. Estrus and Diestrus groups consisted of rats in estrus and diestrus phases, respectively, while COS and PCOS groups consisted of rats with induced COS and PCOS, respectively. The serum AMH, KISS-1, and estradiol levels, and ovarian KISS1r levels were analyzed by enzyme-linked immunosorbent assay. Furthermore, histopathological analysis of the ovary tissue was done and ovarian KISS-1 expression was determined by immunohistochemical assay. The results revealed that ovarian KISS1r levels were higher in the Estrus (1271.43 +/- 51.98 pg/mL) and COS (1191.43 +/- 85.67 pg/mL) groups, compared to Diestrus and PCOS groups. The highest level of AMH was found in the Estrus group (16.91 +/- 2.12 ng/mL). The results indicate that AMH had no effect on the development of COS and PCOS, while KISS-1 was found to affect the development of COS in rats.
dc.description.sponsorshipFirat University Scientific Research Projects Unit [VF.16.25]
dc.description.sponsorshipThis study was supported by the Firat University Scientific Research Projects Unit [VF.16.25]. Some data were obtained from the graduate thesis of Pinar Ipek.
dc.identifier.doi10.17305/bjbms.2019.4281
dc.identifier.endpage43
dc.identifier.issn1512-8601
dc.identifier.issn1840-4812
dc.identifier.issue1
dc.identifier.orcid0000-0002-4907-6159
dc.identifier.orcid0000-0001-5653-0025
dc.identifier.pmid31782699
dc.identifier.scopus2-s2.0-85079092763
dc.identifier.scopusqualityN/A
dc.identifier.startpage37
dc.identifier.urihttps://doi.org/10.17305/bjbms.2019.4281
dc.identifier.urihttps://hdl.handle.net/11508/46164
dc.identifier.volume20
dc.identifier.wosWOS:000512952000005
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAssoc Basic Medical Sci Federation Bosnia & Herzegovina Sarajevo
dc.relation.ispartofBosnian Journal of Basic Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectAnti-Mullerian hormone
dc.subjectkisspeptin
dc.subjectovarian stimulation
dc.subjectpolycystic ovary syndrome
dc.subjectCOS
dc.subjectPCOS
dc.subjectKISS-1
dc.subjectKISS1r
dc.subjectGPR54 receptor
dc.titleExpression of the anti-Mullerian hormone, kisspeptin 1, and kisspeptin 1 receptor in polycystic ovary syndrome and controlled ovarian stimulation rat models
dc.typeArticle

Dosyalar